Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Dec 12, 2018

30786_dirs_2018-12-12_a33f3c52-8e56-412f-a916-4f1d6e2fde3f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-12-11

Reporting Person: TUMOLO ANNETTE (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-11 Bio-Rad A Common Stock S 1176 $254.00 Disposed 1504.3476 Direct
2018-12-11 Bio-Rad A Common Stock M 1200 $159.32 Acquired 2704.3476 Direct
2018-12-11 Bio-Rad A Common Stock S 1200 $255.00 Disposed 1504.3476 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-12-11 Non-Qualified Stock Option (right to buy) $159.32 M 1200 Disposed 2026-09-07 Bio-Rad A Common Stock (1200) Direct

Footnotes

F1: The option vests in five equal annual installments beginning September 7, 2017